Astellas Pharma, Inc. - Company & Market Research Reports

Home /
Companies /
Astellas Pharma, Inc.

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 117
Infectious Diseases Drugs 92
Endocrine and Metabolic Disorders Drugs 74
Central Nervous System Drugs 65
Genomics 59
Immune Disorders Drugs 57
Drug Discovery 49
Pharmaceuticals 44
Diabetes Drugs 42
Prostate Cancer Drugs 42
Vaccines 40
Biopharmaceuticals 39
Clinical Trials 37
Urological Disorders Drugs 35
Dermatological Drugs 33
Women's Health 32
Enzymes 30
Gastrointestinal Drugs 29
Biotechnology 28
Musculoskeletal Disorders Drugs 28
Cardiovascular Drugs 26
Liver and Kidney Disorders Drugs 26
Leukemia Drugs 25
Immunosuppressive Drugs 23
Antibiotics 21
Sexual and Reproductive Health Drugs 21
Optical Disorders Drugs 20
Allergy and Immunology 20
Stem Cells 19
Surgical Procedures 19
Oncology 17
Analgesics 16
Optical 14
Urology and Nephrology 13
Bladder Cancer Drugs 13
Infusions and Injectables 13
Diagnostics 13
Lung Cancer Drugs 12
Medical Devices 12
Drug Delivery 12
Dermatology 11
Pharmaceutical Manufacturing 10
Healthcare Services 9
Respiratory Drugs 9
Therapeutic Area 8
Neurology 8
Pulmonary Medicine 7
Lymphoma Drugs 7
Hearing Aids and Implants 7
Mental Disorders Drugs 7
Kidney Cancer Drugs 7
Gastroenterology 7
Pharmaceutical Intermediates 6
Biomaterials 6
Needles and Syringes 6
Hematology 6
Over the Counter (OTC) Drugs 6
Proteomics 5
Managed Care 5
Hematological Drugs 5
Allergy Drugs 5
Brain Cancer Drugs 4
Cardiovascular Devices 4
Infectious Disease Testing 4
Cancer Vaccines 4
Pancreatic Cancer Drugs 4
Pediatrics 4
Company Reports 3
Drugs by Therapeutic Area 3
Colon Cancer Drugs 3
In Vitro Diagnostics 3
Mental Health 3
Skin Cancer Drugs 3
Schizophrenia Drugs 3
Liver Cancer Drugs 2
Breast Cancer Drugs 2
Ovarian Cancer Drugs 2
Medical Imaging 2
Glucose Testing 2
Cough and Cold Drugs 2
Diabetes Devices 2
Transdermal and Transmucosal Drug Delivery 2
Biomarkers 2
Surgical Devices 2
Thyroid Cancer Drugs 2
Laboratory Equipment 2
Cardiology 2
Asthma Drugs 2
Addiction Disorders Drugs 1
Patient Monitoring Equipment 1
E-Healthcare 1
Pharmacoeconomics 1
Fertility Services 1
Bioinformatics 1
Dialysis 1
Healthcare 1
Dental 1
Hospital Management 1
Alternative and Complementary Medicine 1
Molecular Diagnostics 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1
Biosimilars and Biosuperiors 1
Nanomedicine 1
Anti-Obesity Drugs 1
Palliative Care 1
Anatomy 1
Endocrinology 1
Acne Drugs 1
Alzheimer's Disease Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

1,146 Results (Page 7 of 58)
- Relevance
  Sort by

Schizophrenia Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4006EUR$4,490USD£3,533GBP

Endometriosis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2024
99 Pages
Global

From

€3500EUR$4,202USD£3,194GBP

Diabetic Neuropathic Pain- Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1071EUR$1,200USD£944GBP

€1338EUR$1,500USD£1,180GBP

Immunology Collaboration and Licensing Deals 2016-2025

 Report
October 2025
500 Pages
Global

From

€3565EUR$3,995USD£3,143GBP

Pertussis Vaccines - Global Strategic Business Report

 Report
November 2025
285 Pages
Global

From

€5220EUR$5,850USD£4,603GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World

 Report
November 2023
63 Pages
Global

€8217EUR$9,531USD£7,000GBP

Uterine Fibroid Embolization Agent Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
77 Pages
Global

From

€3500EUR$4,202USD£3,194GBP

Monoclonal Antibody Collaboration and Licensing Deals 2019-2025

 Report
May 2025
350 Pages
Global

From

€3565EUR$3,995USD£3,143GBP

Castrate-resistant Prostate Cancer (CRPC) - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€5675EUR$6,360USD£5,004GBP

€7094EUR$7,950USD£6,255GBP

Gout Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

 Report
May 2025
93 Pages
Global

From

€3500EUR$4,202USD£3,194GBP

United Kingdom Prostate Cancer Therapeutics Market, Competition, Forecast and Opportunities, 2018-2028

 Report
October 2023
81 Pages
United Kingdom

From

€3123EUR$3,500USD£2,754GBP

Needle-Free Devices: Technologies and Global Markets

 Report
June 2025
156 Pages
Global

From

€4149EUR$4,650USD£3,658GBP

Metastatic Prostate Cancer - Market Insight, Epidemiology And Market Forecast - 2032

 Report
November 2023
432 Pages
Global

From

€6781EUR$7,600USD£5,979GBP

€8477EUR$9,500USD£7,474GBP

Hypoxia Inducible Factor Prolyl-4-Hydroxylase (HIF-PH) Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€892EUR$1,000USD£787GBP

€1115EUR$1,250USD£983GBP

Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2020-2025

 Report
August 2025
1500 Pages +
Global

From

€4457EUR$4,995USD£3,930GBP

Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
1663 Pages
Global

From

€2231EUR$2,500USD£1,967GBP

Antibiotics Market 2025-2029

 Report
January 2025
198 Pages
Global

From

€2231EUR$2,500USD£1,967GBP

Overactive Bladder Treatment Market - Global Forecast 2025-2032

 Report
October 2025
197 Pages
Global

From

€3163EUR$3,545USD£2,789GBP

€3515EUR$3,939USD£3,099GBP

Genitourinary Drugs Market - Global Forecast 2025-2032

 Report
October 2025
197 Pages
Global

From

€3163EUR$3,545USD£2,789GBP

€3515EUR$3,939USD£3,099GBP

Human Papillomavirus (HPV) Vaccine Market Report 2025

 Report
September 2025
250 Pages
Global

From

€4006EUR$4,490USD£3,533GBP

1,146 Results (Page 7 of 58)
- 1
- 5
- 6
- 7
- 8
- 9

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.